Harbin Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 27.3% in First Quarter of 2023

Harbin Pharmaceutical Group Co.,Ltd. (哈药集团股份有限公司) (600664.SH) reported a net profit of 140 million yuan in the first quarter of 2023, up 27.3% year-on-year.

Meanwhile, the company posted 3.9 billion yuan in revenue, up 17.9% year-on-year.

At the end of the reporting period, it had 13.5 billion yuan in total assets and 8.4 billion yuan in total liabilities, with a liability-to-asset ratio of 62.4%.